Patent intelligence · US
US 2020030465
Stable, concentrated radionuclide complex solutions
Stable, concentrated radionuclide complex solutions
Patent details — US 2020030465
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 30, 2020
- Expiration
- Jan 25, 2040
- CPC classes
- A61K 51/ 08 A I, A61K/5108, A61K/51083, A61K/51121
Quick answer
US 2020030465 (Stable, concentrated radionuclide complex solutions) is held by ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT]. Status: granted. Granted Jan 30, 2020. Expires Jan 25, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 51/ 08 A I, A61K/5108, A61K/51083, A61K/51121
More from ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT]
Related pharmaceutical patents in our USPTO index.
-
EP 4541380
STABILE KONZENTRIERTE RADIONUKLID-KOMPLEX-LÖSUNGEN
granted -
CA 3235923
PROCEDES DE SYNTHESE A GRANDE ECHELLE DE COMPLEXES DE RADIONUCLEIDES
granted -
CA 3240096
POLYTHERAPIE POUR LE TRAITEMENT DU CANCER DU POUMON
granted -
CA 3234495
POLYTHERAPIE DE COMPLEXE DE RADIONUCLEIDES
granted -
CA 3215723
PROCEDES DE DIAGNOSTIC DU CANCER DE LA PROSTATE
granted -
CA 3202908
ANTAGONISTE D'INTEGRINES ALPHA-V BETA-3 ET/OU ALPHA-V BETA-5 RADIOMARQUE DESTINE A ETRE UTILISE EN TANT QU'AGENT THERAGNOSTIQUE
granted -
US 2022072166
METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS
granted -
WO 2022043557
MÉTHODE DE TRAITEMENT DE CANCERS EXPRIMANT LE PSMA
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 2020030465?
US 2020030465 (Stable, concentrated radionuclide complex solutions) is held by ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT]. Status: granted. Granted Jan 30, 2020. Expires Jan 25, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2020030465?
ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2020030465 expire?
Our index shows an expiration date of Jan 25, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.